Cargando…
Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2
Glucocorticoids are used widely on a long-term basis in autoimmune and inflammatory diseases. Their adverse effects include the development of hyperglycemia and osteoporosis, whose molecular mechanisms have been only partially studied in preclinical models. Both these glucocorticoid-induced patholog...
Autores principales: | Filippopoulou, Fotini, Habeos, George I., Rinotas, Vagelis, Sophocleous, Antonia, Sykiotis, Gerasimos P., Douni, Eleni, Chartoumpekis, Dionysios V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773000/ https://www.ncbi.nlm.nih.gov/pubmed/35052508 http://dx.doi.org/10.3390/antiox11010004 |
Ejemplares similares
-
Chronic Dexamethasone Treatment Leads to Less Weight Gain and Ameliorated Glucose Tolerance in Mice; Role of the Cytoprotective Nrf2 Pathway
por: Filippopoulou, Fotini, et al.
Publicado: (2021) -
SAT046 Canagliflozin Leads To Less Weight Gain, Confers Changes In The Gut Microbiota And Extends Life Span In Male C57BL6 Mice
por: Habeos, Evagelia E, et al.
Publicado: (2023) -
SAT-455 Mouse Thyroid Responds to Iodine Overload by Transcriptionally Enhancing the Keap1/Nrf2 Antioxidant Response and by Upregulating Nrf2-Dependent and Independent Inflammatory and Fibrosis Pathways
por: Chartoumpekis, Dionysios V, et al.
Publicado: (2020) -
Maternal Calorie Restriction Induces a Transcriptional Cytoprotective Response in Embryonic Liver Partially Dependent on Nrf2
por: Habeos, George I., et al.
Publicado: (2022) -
Nrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2011)